GLP-1 Market
LLY $1183.46 ▲ +0.1% NVO $38.80 ▲ +0.5% PFE $28.67 ▲ +0.9% VKTX $35.56 ▼ -3.2% KLRA $11.21 ▼ -6.4% GPCR $35.93 ▼ -0.2% RHHBY $54.41 ▼ -0.7%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Intranasal insulin

Company
Centre for Addiction and Mental Health
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
18 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

18 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 26, 2026

Find a Clinical Trial Near Me

See recruiting studies for Intranasal insulin and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT03087032

    Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)

    Not yet reported The First Affiliated Hospital of Xiamen University 164 participants Est. completion 2025-02-10 1 site
    Type 2 diabetes Other conditions: Overweight and Obesity, Hyperglycaemia (Diabetic)
    View official trial listing →
  • Recruiting NCT NCT03463564

    Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients

    Not yet reported University of Campania Luigi Vanvitelli 150 participants Est. completion 2026-12 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT05266417

    Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease

    Not yet reported Gateway Institute for Brain Research 56 participants Est. completion 2027-11-30 4 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT05988632

    Intranasal Insulin for Treatment of Alcohol Use Disorder

    Not yet reported, Not yet reported Brown University 40 participants Est. completion 2027-01-31 1 site
    Alcohol use disorder
    View official trial listing →
  • Recruiting NCT NCT06039787

    Exercise Training on Brain Insulin Responsiveness

    Not yet reported University Hospital Tuebingen 40 participants Est. completion 2026-12-31 1 site
    Other conditions: Insulin Resistance, Obesity
    View official trial listing →
  • Recruiting NCT NCT06072963

    COMMETS- Combination MCI Metabolic Syndrome

    Not yet reported Rutgers, The State University of New Jersey 80 participants Est. completion 2028-12-01 1 site Added to GLP-1
    Metabolic syndrome Other conditions: Alzheimer Disease, Mild Cognitive Impairment
    View official trial listing →
  • Recruiting NCT NCT06251635

    Effects of Antipsychotics on Brain Insulin Action in Females

    Not yet reported Centre for Addiction and Mental Health 15 participants Est. completion 2026-08-01 1 site Stand-alone
    Type 2 diabetes Other conditions: Insulin Resistance, Menstrual Cycle, Antipsychotics
    View official trial listing →
  • Recruiting NCT NCT06280703

    A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

    Not yet reported Eli Lilly and Company 118 participants Est. completion 2026-09 1 site
    Other conditions: Healthy, Type 1 Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT06419777

    Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes

    Not yet reported Thomas Jefferson University 430 participants Est. completion 2026-05 2 sites
    Other conditions: Gestational Diabetes, Pregnancy Related
    View official trial listing →
  • Recruiting NCT NCT06419803

    Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)

    Not yet reported Thomas Jefferson University 430 participants Est. completion 2026-05 2 sites
    Other conditions: Gestational Diabetes, Pregnancy Related
    View official trial listing →
  • Recruiting NCT NCT06445946

    DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

    Not yet reported Ohio State University 1572 participants Est. completion 2030-12 24 sites Stand-alone
    Other conditions: Gestational Diabetes Mellitus, Pregnancy, High Risk
    View official trial listing →
  • Recruiting NCT NCT06532461

    A Trial of Three- and Seven-days Insulin Infusions Set

    Not yet reported Steno Diabetes Center Copenhagen 80 participants Est. completion 2026-12-31 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Recruiting NCT NCT06945406

    A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes

    Not yet reported Eli Lilly and Company 124 participants Est. completion 2026-12 1 site
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Recruiting NCT NCT07109245

    Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?

    Not yet reported Centre for Addiction and Mental Health 35 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Brain Insulin Sensitivity, Healthy Controls, Cognition
    View official trial listing →
  • Recruiting NCT NCT07171684

    Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)

    Not yet reported Rutgers, The State University of New Jersey 176 participants Est. completion 2027-05-15 2 sites
    Other conditions: Diabetes in Pregnancy, Gestational Diabetes
    View official trial listing →
  • Recruiting NCT NCT07384052

    Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury

    Not yet reported HealthPartners Institute 12 participants Est. completion 2027-01 1 site Stand-alone
    Other conditions: Spinal Cord Injury
    View official trial listing →
  • Recruiting NCT NCT07422220

    Long-Term Effects of Walnut Consumption on Brain Function

    Not yet reported Maastricht University Medical Center 55 participants Est. completion 2027-08 1 site
    Other conditions: Healthy, Brain Insulin Sensitivity, Cerebral Blood Flow, Brain Vascular Function, Satiety and Food Intake, Food Reward, Cognitive Performance, Abdominal Obesity, Cognitive Decline
    View official trial listing →
  • Recruiting NCT NCT07675499

    Exercise and Intranasal Insulin in Type 2 Diabetes

    Not yet reported, Not yet reported Rutgers, The State University of New Jersey 60 participants Est. completion 2029-05-31 4 sites
    Type 2 diabetes Other conditions: Insulin Sensitivity/Resistance, Cognition, Brain Blood Flow
    View official trial listing →
  • Completed NCT NCT00036504

    Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin

    Not yet reported Eli Lilly and Company 100 participants Est. completion 2002-08 13 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00046501

    Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents

    Not yet reported Sanofi 250 participants 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00063128

    Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.

    Not yet reported Eli Lilly and Company 119 participants Est. completion 2004-04 25 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00071448

    Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population

    Not yet reported Novo Nordisk A/S 378 participants Est. completion 2004-06 76 sites
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00097071

    Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents

    Not yet reported Novo Nordisk A/S 299 participants Est. completion 2006-05 52 sites
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00110370

    Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 Diabetes

    Not yet reported Eli Lilly and Company 300 participants Est. completion 2006-04 48 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00115570

    Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents

    Not yet reported Sanofi 572 participants Est. completion 2006-11 1 site
    Other conditions: Diabetes Mellitus, Insulin-Dependent
    View official trial listing →
  • Completed NCT NCT00135941

    Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)

    Not yet reported Sanofi 582 participants Est. completion 2007-09 1 site Stand-alone
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00191178

    Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes

    Not yet reported Eli Lilly and Company 60 participants Est. completion 2005-07 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00191282

    Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes

    Not yet reported Eli Lilly and Company 1116 participants Est. completion 2007-10 17 sites
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Completed NCT NCT00191464

    Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes

    Not yet reported Eli Lilly and Company 320 participants Est. completion 2005-09 7 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00191581

    Local Registration Trial in China Humalog Mix 50

    Not yet reported Eli Lilly and Company 120 participants Est. completion 2006-04 2 sites
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT00223613

    Intranasal Insulin for Prevention of Type 1 Diabetes

    Not yet reported University of Turku 240 participants Est. completion 2005-08 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Withdrawn NCT NCT00228904

    Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes

    Not yet reported, Not yet reported Florida Atlantic University Est. completion 2011-10 1 site
    Other conditions: Diabetic Neuropathy
    View official trial listing →
  • Completed NCT NCT00231725

    Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin

    Not yet reported Eli Lilly and Company 370 participants Est. completion 2006-04 4 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00279201

    The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)

    Not yet reported Eli Lilly and Company 2091 participants Est. completion 2009-11 199 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00290979

    Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus

    Not yet reported Sanofi 250 participants 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00297583

    Insulin Glulisine in Type 1 Diabetes Mellitus

    Not yet reported Sanofi
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00310297

    Insulin Glulisine in Type 2 Diabetes Mellitus

    Not yet reported Sanofi
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00311077

    Insulin Glulisine in Healthy Lean and Obese Subjects

    Not yet reported Sanofi
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00311818

    Insulin Glargine in Type 2 Diabetes Mellitus

    Not yet reported Sanofi
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00314314

    The Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Bipolar Disorder

    Not yet reported University Health Network, Toronto 60 participants Est. completion 2009-03 1 site Stand-alone
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00336674

    Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 Diabetes

    Not yet reported Melbourne Health 110 participants Est. completion 2019-11-13 6 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00348374

    Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes

    Not yet reported Pfizer 191 participants Est. completion 2008-08 63 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT00356421

    A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®

    Not yet reported Pfizer 58 participants Est. completion 2008-06 23 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00377858

    Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX)

    Not yet reported Eli Lilly and Company 484 participants Est. completion 2008-09 25 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00393705

    Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)

    Not yet reported Eli Lilly and Company 302 participants Est. completion 2009-03 9 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00420095

    A Study for Patients With Diabetes Mellitus (IOPA)

    Not yet reported Eli Lilly and Company 117 participants Est. completion 2008-01 4 sites
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT00428207

    Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy

    Not yet reported Joslin Diabetes Center 4 participants Est. completion 2008-08 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00438568

    SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)

    Not yet reported University of Washington 173 participants Est. completion 2011-12 1 site
    Other conditions: Mild Cognitive Impairment, Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT00442767

    Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus

    Not yet reported Montefiore Medical Center 8 participants Est. completion 2009-02 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00461331

    Comparison of Insulins Aspart and Lispro in Insulin Pumps

    Not yet reported Tulane University Health Sciences Center 20 participants Est. completion 2008-08 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT00464854

    Glucose Control With Multiple Daily Insulin Injections In Diabetic Patients Hospitalized In A General Medicine Ward

    Not yet reported Assaf-Harofeh Medical Center 100 participants Est. completion 2006-09 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00467376

    Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus

    Not yet reported Sanofi 485 participants 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00467649

    A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes

    Not yet reported AstraZeneca 112 participants Est. completion 2008-04 37 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00468754

    A Study Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections With Insulin Lispro and Glargine

    Not yet reported Hoffmann-La Roche 50 participants Est. completion 2005-05 4 sites
    Other conditions: Diabetes Mellitus Type 1
    View official trial listing →
  • Completed NCT NCT00487240

    Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes

    Not yet reported Eli Lilly and Company 387 participants Est. completion 2008-08 28 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00494013

    Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)

    Not yet reported Eli Lilly and Company 442 participants Est. completion 2008-09 56 sites
    Type 2 diabetes
    View official trial listing →
  • Withdrawn NCT NCT00505882

    Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2008-12 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00510952

    Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE)

    Not yet reported Eli Lilly and Company 471 participants Est. completion 2008-10 17 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00513201

    Lyspro Insulin vs Regular Insulin in Cirrhotic Patients

    Not yet reported University of Campania Luigi Vanvitelli 1 site
    Other conditions: Diabetes Mellitus, Cirrhosis
    View official trial listing →
  • Completed NCT NCT00537251

    32 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes Mellitus

    Not yet reported Sanofi 80 participants Est. completion 2004-02
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00540709

    PUMP STUDY MDI Lantus/Lispro vs Continuous Insulin+Lispro

    Not yet reported Sanofi 58 participants Est. completion 2003-09
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00548808

    A Study for Type 2 Diabetic Patients

    Not yet reported Eli Lilly and Company 426 participants Est. completion 2009-08 25 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00551356

    Lispro Mix 25 vs. Glargine in Type 2 Diabetics

    Not yet reported Eli Lilly and Company 53 participants Est. completion 2003-07 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00551538

    24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine

    Not yet reported Eli Lilly and Company 15 participants Est. completion 2004-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00553488

    Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating

    Not yet reported Becton, Dickinson and Company 30 participants Est. completion 2008-01 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00560417

    Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide

    Not yet reported Eli Lilly and Company 339 participants Est. completion 2009-12 52 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00570050

    Effect of Intranasal Insulin on Depressive Symptoms in Major Depressive Disorder

    Not yet reported University Health Network, Toronto 35 participants Est. completion 2014-09 1 site Stand-alone
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT00574405

    Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy

    Not yet reported Arkansas Children's Hospital Research Institute 24 participants Est. completion 2011-03 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00575666

    Intranasal Insulin Treatment in Patients With Schizophrenia

    Not yet reported University of Massachusetts, Worcester 45 participants Est. completion 2010-09 1 site Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00581867

    Memory and Insulin in Early Alzheimer's Disease

    Not yet reported, Not yet reported Jeff Burns, MD 31 participants Est. completion 2012-05 1 site Stand-alone
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT00607087

    Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus

    Not yet reported Sanofi 289 participants Est. completion 2009-06 12 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00624767

    A Study to Evaluate the Effect of Nasal Insulin on Postprandial Glycemic Control in Type 2 Diabetic Patients

    Not yet reported Nastech Pharmaceutical Company, Inc. 18 participants Est. completion 2008-05 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00641407

    Bedtime Insulins and Oral Antihyperglycemic Drugs in Type 2 Diabetes

    Not yet reported University of Campania Luigi Vanvitelli 100 participants Est. completion 2008-03 1 site
    Type 2 diabetes Other conditions: Hypoglycemia
    View official trial listing →
  • Completed NCT NCT00646581

    Effect of Single Dose Intranasal Insulin On Cognitive Function

    Not yet reported University of Massachusetts, Worcester 30 participants Est. completion 2010-01 1 site Stand-alone
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00652288

    Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs

    Not yet reported Yale University 36 participants Est. completion 2011-09
    Other conditions: Diabetes Mellitus, Type I
    View official trial listing →
  • Completed NCT NCT00662857

    A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin Lispro

    Not yet reported Mannkind Corporation 29 participants Est. completion 2008-12 2 sites
    Other conditions: Diabetes Mellitus: Type 1
    View official trial listing →
  • Completed NCT NCT00664534

    Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast

    Not yet reported Eli Lilly and Company 344 participants Est. completion 2010-11 27 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00666718

    A Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes Patients

    Not yet reported Eli Lilly and Company 374 participants Est. completion 2010-02 50 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00700622

    Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks

    Not yet reported Mannkind Corporation 130 participants Est. completion 2010-03 22 sites Stand-alone
    Other conditions: Diabetes, Type 1
    View official trial listing →
  • Completed NCT NCT00705536

    Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20

    Not yet reported Halozyme Therapeutics 26 participants Est. completion 2008-02 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT00747006

    Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate Intake

    Not yet reported Mannkind Corporation 18 participants Est. completion 2011-05 1 site
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00774800

    Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus

    Not yet reported Halozyme Therapeutics 22 participants Est. completion 2009-03 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00803972

    Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20

    Not yet reported Halozyme Therapeutics 42 participants Est. completion 2009-08-28 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT00806975

    Comparison of Novo Rapid 30 Mix Injection FlexPen® and Humalog 25 Mix Injection KwikPen® in Type 2 Diabetic Patients

    Not yet reported Nagaoka Red Cross Hospital 200 participants Est. completion 2009-06 1 site
    Type 2 diabetes Other conditions: Diabetes Complications
    View official trial listing →
  • Completed NCT NCT00810589

    A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial

    Not yet reported Medical University of Graz 30 participants Est. completion 2008-12 1 site
    Other conditions: Diabetes, Type I
    View official trial listing →
  • Completed NCT NCT00841919

    Insulin Therapy in the Hospital Comparing Two Protocols

    Not yet reported Cook County Health 60 participants Est. completion 2009-06 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00849576

    Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus.

    Not yet reported Biodel 15 participants Est. completion 2008-08 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00850096

    Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus

    Not yet reported CPEX Pharmaceuticals Inc. 94 participants Est. completion 2010-03 21 sites
    Type 2 diabetes
    View official trial listing →
  • Withdrawn NCT NCT00850161

    Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin

    Not yet reported CPEX Pharmaceuticals Inc. Est. completion 2010-09 Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00862849

    Pharmacokinetic and Glucodynamic Crossover Study of Subcutaneously (SC) Administered Insulin Lispro + Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin + rHuPH20 Compared to Insulin Lispro Alone

    Not yet reported Halozyme Therapeutics 22 participants Est. completion 2009-08 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00874809

    Diabetes Mellitus Type 2 Basal Insulin Dosing Requirements Study

    Not yet reported Diabetes Care Center 30 participants Est. completion 2011-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00883558

    Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus

    Not yet reported Halozyme Therapeutics 48 participants Est. completion 2010-04 8 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Withdrawn NCT NCT00916201

    Evaluation Study of New Compounds With Potential Use in Schizophrenia

    Not yet reported Central Institute of Mental Health, Mannheim Est. completion 2025-01-31 1 site Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00916357

    Liquid Meal Study With Insulin Lispro With/Without Recombinant Human Hyaluronidase PH20 (rHuPH20) and Regular Human Insulin With rHuPH20 to Compare Pharmacokinetics, Postprandial Glycemic Response, and Optimal Insulin Dose in Participants With Type 2 Diabetes Mellitus (T2DM)

    Not yet reported Halozyme Therapeutics 23 participants Est. completion 2009-11 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00927524

    Insulin Exposure and Glucose Response to Meals in Type 1 Diabetic Subjects Administered Two Different Insulin Regimens Compared to the Endogenous Insulin Exposure and Glucose Response to Meals In Healthy Adult Controls

    Not yet reported Vanderbilt University 24 participants Est. completion 2010-12
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00960661

    A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes

    Not yet reported AstraZeneca 1036 participants Est. completion 2012-08 95 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00971997

    A Study of Insulin Lispro Mix in Type 2 Diabetic Asian Patients

    Not yet reported Eli Lilly and Company 135 participants Est. completion 2011-04 14 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00976391

    A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine

    Not yet reported GlaxoSmithKline 586 participants Est. completion 2012-05 209 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00977808

    Pilot Study of Closed-Loop Glucose Control in People With Type 1 Diabetes (BPK004)

    Not yet reported University of Virginia 12 participants Est. completion 2009-02 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00979875

    A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs Alone

    Not yet reported Halozyme Therapeutics 14 participants Est. completion 2010-05 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00985712

    A Study on the Effect of 2 Pen Devices on HbA1c

    Not yet reported Eli Lilly and Company 263 participants Est. completion 2011-07 29 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00993473

    6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes

    Not yet reported Sanofi 125 participants Est. completion 2011-03 61 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01000922

    A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro

    Not yet reported Biodel 24 participants Est. completion 2008-01 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT01023165

    Effects of Intensive Bolus Intravenous Insulin Delivery on Metabolic Integrity in Type 1 and Type 2 Diabetes

    Not yet reported Global Infusion and Aspiration Systems, LLC 2000 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Metabolic Integrity
    View official trial listing →
  • Terminated NCT NCT01035801

    Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients

    Not yet reported Biocon Limited 20 participants Est. completion 2011-03-12 5 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT01045954

    A Study of the Rules for Insulin Dosing in Patients Using Multiple Daily Injections

    Not yet reported Diabetes Care Center 50 participants Est. completion 2010-10 1 site
    Other conditions: Diabetes Mellitus Type 1
    View official trial listing →
  • Withdrawn NCT NCT01067118

    A Randomized Control Trial Comparing Linjeta Versus Humalog in Pumps: Effect on Postprandial Blood Sugars.

    Not yet reported Stanford University Est. completion 2011-06 2 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01068860

    To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies

    Not yet reported Novartis 246 participants Est. completion 2010-08 52 sites
    Type 2 diabetesPrediabetes
    View official trial listing →
  • Completed NCT NCT01109316

    Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use

    Not yet reported Eli Lilly and Company 132 participants Est. completion 2011-08 11 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01110746

    To Evaluate the Effect on Post-prandial Glycemia Safety, and Tolerability of Viaject 7 vs. Lispro Insulin During Subcutaneous Insulin Pump Therapy

    Not yet reported Biodel 20 participants Est. completion 2010-06 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01120444

    Study on the Effects on Blood Glucose Following Intradermal and Subcutaneous Dosing of Insulin in Diabetic Patients

    Not yet reported, Not yet reported Becton, Dickinson and Company 20 participants Est. completion 2010-10 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01121835

    Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study

    Not yet reported Sanofi 934 participants Est. completion 2012-03 96 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01133392

    Bioequivalence of Two Lispro Formulations

    Not yet reported Eli Lilly and Company 41 participants Est. completion 2010-08 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01134107

    Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use

    Not yet reported Eli Lilly and Company 133 participants Est. completion 2011-12 15 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT01136746

    Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin

    Not yet reported Eli Lilly and Company 16 participants Est. completion 2011-11 12 sites
    Other conditions: Hyperglycemia
    View official trial listing →
  • Completed NCT NCT01147627

    Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients

    Not yet reported Sun Yat-sen University 416 participants Est. completion 2012-12 25 sites
    Type 2 diabetes Other conditions: Newly Diagnosed
    View official trial listing →
  • Status unknown NCT NCT01149005

    Cystic Fibrosis (CF) Exacerbation and Insulin Treatment

    Not yet reported Hadassah Medical Organization 30 participants Est. completion 2015-12 1 site Stand-alone
    Prediabetes Other conditions: Cystic Fibrosis, Pulmonary Exacerbation
    View official trial listing →
  • Completed NCT NCT01159938

    A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes

    Not yet reported Eli Lilly and Company 72 participants Est. completion 2013-02 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01175811

    A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 402 participants Est. completion 2012-11 14 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01175824

    Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies

    Not yet reported Eli Lilly and Company 478 participants Est. completion 2012-11 18 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01184014

    Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia

    Not yet reported HealthPartners Institute 72 participants Est. completion 2012-08 1 site
    Other conditions: Hyperglycemia
    View official trial listing →
  • Completed NCT NCT01191268

    A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)

    Not yet reported Eli Lilly and Company 884 participants Est. completion 2012-09 101 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01194245

    Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus

    Not yet reported Halozyme Therapeutics 135 participants Est. completion 2011-08 19 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01194258

    Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus

    Not yet reported Halozyme Therapeutics 132 participants Est. completion 2011-08 22 sites
    Other conditions: Diabetes Mellitus, Type II
    View official trial listing →
  • Status unknown NCT NCT01201278

    PK/PD Study of Intranasal Insulin in Type I Diabetes

    Not yet reported Hompesch, Marcus, M.D. 20 participants 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01206322

    Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes

    Not yet reported Beth Israel Deaconess Medical Center 30 participants Est. completion 2013-04 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01213901

    Optimizing Insulin Absorption and Insulin Injection Technique in Older Adults

    Not yet reported University of British Columbia 20 participants Est. completion 2014-03 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01215955

    Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes

    Not yet reported Eli Lilly and Company 1117 participants Est. completion 2013-01 76 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01216618

    Evaluation of the Effect of the InsuPatch Device on Insulin Pharmacokinetics in Clamp Studies

    Not yet reported Insuline Medical Ltd. 55 participants Est. completion 2011-06 3 sites
    Other conditions: Diabetes Mellitus, Insulin-Dependent
    View official trial listing →
  • Completed NCT NCT01235039

    A Study Evaluating the Bioequivalence of VIAject®7 Compared to VIAject®25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject®7 to Insulin Lispro in Subjects With Type 1 Diabetes Mellitus

    Not yet reported, Not yet reported Biodel 43 participants Est. completion 2009-09 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01240785

    Metformin Versus Insulin in Gestational Diabetes

    Not yet reported Turku University Hospital 221 participants Est. completion 2012-12
    Other conditions: Gestational Diabetes
    View official trial listing →
  • Completed NCT NCT01269034

    New Onset Type 1 Diabetes: Role of Exenatide

    Not yet reported Albert Einstein College of Medicine 13 participants Est. completion 2017-01-31 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01269047

    Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia

    Not yet reported Albert Einstein College of Medicine 37 participants Est. completion 2016-12 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01283425

    Evaluation of the Safety Use of the InsuPatch Device in Daily Life Conditions

    Not yet reported Insuline Medical Ltd. 147 participants Est. completion 2012-04 8 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01300260

    Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose

    Not yet reported Eli Lilly and Company 32 participants Est. completion 2011-08 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT01303042

    Efficacy of Insulin Lispro Mix 50/50 Therapy

    Not yet reported Aichi Gakuin University 80 participants Est. completion 2014-12 4 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01311076

    TAK-329 Glucose Clamp Study

    Not yet reported Takeda 37 participants Est. completion 2012-01 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01334151

    Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog® in Subjects With Type 1 Diabetes

    Not yet reported Biodel 13 participants Est. completion 2011-08 1 site
    Other conditions: Diabetes Mellitus Type 1
    View official trial listing →
  • Completed NCT NCT01336751

    Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment

    Not yet reported Sanofi 212 participants Est. completion 2002-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01378117

    Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes

    Not yet reported Emory University 90 participants Est. completion 2012-06 2 sites
    Type 2 diabetes Other conditions: Hospitalization, Hyperglycemia
    View official trial listing →
  • Withdrawn NCT NCT01398670

    Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics

    Not yet reported Wockhardt Est. completion 2013-05
    Other conditions: Type I Diabetes
    View official trial listing →
  • Withdrawn NCT NCT01399255

    Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy Subjects

    Not yet reported Wockhardt Est. completion 2012-06 1 site
    Other conditions: Bioequivalence in Healthy Subjects
    View official trial listing →
  • Withdrawn NCT NCT01400789

    Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Listro Mix 50/50® and Humalog Mix50/50® in Healthy Subjects

    Not yet reported Wockhardt 1 site
    Other conditions: Bioequivalence in Healthy Subjects
    View official trial listing →
  • Withdrawn NCT NCT01400802

    Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Mixture Listro Mix 75/25® and Humalog Mix75/25 ® in Healthy Subjects

    Not yet reported Wockhardt Est. completion 2012-06 1 site
    Other conditions: Bioequivalence in Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT01406496

    Best Timing of Insulin Bolus Before Meals of Different Contents

    Not yet reported Kaplan Medical Center 24 participants Est. completion 2013-12 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01421147

    A Study in Adults With Type 1 Diabetes

    Not yet reported Eli Lilly and Company 536 participants Est. completion 2013-04 52 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01436045

    Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.

    Not yet reported HealthPartners Institute 12 participants Est. completion 2013-06 1 site
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT01454284

    A Study in Participants With Type I Diabetes Mellitus

    Not yet reported Eli Lilly and Company 1114 participants Est. completion 2014-02 119 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01468987

    A Study in Participants With Type 2 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 1369 participants Est. completion 2013-08 156 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01469559

    Safety Study of Intranasal Insulin in Type 1 Diabetes and Diabetic Peripheral Neuropathy

    Not yet reported University of Calgary 12 participants Est. completion 2012-07 1 site
    Other conditions: Diabetic Peripheral Neuropathy
    View official trial listing →
  • Completed NCT NCT01474538

    Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy

    Not yet reported Eli Lilly and Company 122 participants Est. completion 2013-02 12 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01479075

    The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism

    Not yet reported German Diabetes Center 30 participants Est. completion 2014-06 1 site Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01481779

    A Study in Participants With Type 1 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 455 participants Est. completion 2014-06 51 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01524705

    FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)

    Not yet reported University of Washington 102 participants Est. completion 2014-07 12 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01526733

    Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase

    Not yet reported Halozyme Therapeutics 25 participants Est. completion 2013-09 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01531855

    Post-exercise Insulin Reductions in Type 1 Diabetes

    Not yet reported Northumbria University 13 participants Est. completion 2012-08 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01547169

    Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days

    Not yet reported University of Washington 60 participants Est. completion 2012-12 1 site
    Other conditions: Alzheimer's Disease, Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT01561378

    Cardiac Surgery Neuroprotection Study in Elders

    Not yet reported Albert Einstein College of Medicine 22 participants Est. completion 2014-10 1 site
    Other conditions: Post-operative Cognitive Decline, Post-operative Delirium
    View official trial listing →
  • Completed NCT NCT01595646

    Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)

    Not yet reported Wake Forest University Health Sciences 37 participants Est. completion 2015-03-12 2 sites
    Other conditions: Alzheimer's Disease, Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT01613807

    Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes

    Not yet reported Sansum Diabetes Research Institute 40 participants Est. completion 2010-10 Stand-alone
    Other conditions: Gestational Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01621178

    A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)

    Not yet reported Eli Lilly and Company 577 participants Est. completion 2016-12 89 sites
    Type 2 diabetesChronic kidney disease
    View official trial listing →
  • Completed NCT NCT01621776

    Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia

    Not yet reported University of Florida 107 participants Est. completion 2012-08 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Withdrawn NCT NCT01636596

    Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease

    Not yet reported Louisiana State University Health Sciences Center Shreveport Est. completion 2015-01 1 site
    Other conditions: Alzheimer's Disease, Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT01638325

    A Study of Insulin Lispro With BioChaperone Excipient in Healthy Participants

    Not yet reported Adocia 37 participants Est. completion 2012-09 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT01662921

    Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes

    Not yet reported Sansum Diabetes Research Institute 17 participants Est. completion 2015-08-31 1 site
    Other conditions: Diabetes During Pregnancy
    View official trial listing →
  • Completed NCT NCT01680185

    Sensor-Augmented Insulin-Pump Therapy in New-onset Diabetes After Transplantation

    Not yet reported Medical University of Vienna 85 participants Est. completion 2018-05 1 site
    Other conditions: Hyperglycemia
    View official trial listing →
  • Completed NCT NCT01684943

    Selecting Insulin Analogs for Closed-Loop Control Using Multiplex Pharmacokinetic Profiling

    Not yet reported Massachusetts General Hospital 33 participants Est. completion 2017-12 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01686620

    A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

    Not yet reported Biodel 132 participants Est. completion 2013-06 34 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01755468

    Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study)

    Not yet reported Mount Sinai Hospital, Canada 24 participants Est. completion 2017-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT01756105

    Efficacy of Metformin in Achieving Glycaemia Goals as Recommended for the Treatment of Gestational Diabetes in Non Obese Women

    Not yet reported University Hospital, Strasbourg, France 84 participants Est. completion 2018-06 5 sites Stand-alone
    Other conditions: Gestational Diabetes, Metformin, Treatment, Oxidative Stress
    View official trial listing →
  • Completed NCT NCT01762059

    Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas

    Not yet reported Massachusetts General Hospital 32 participants Est. completion 2014-06 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01767909

    The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

    Not yet reported, Not yet reported University of Southern California 240 participants Est. completion 2018-12-11 25 sites
    Other conditions: Amnestic Mild Cognitive Impairment, Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT01773473

    Comparison of Insulin Mix25 Versus Mix50

    Not yet reported Eli Lilly and Company 403 participants Est. completion 2014-08 27 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01776788

    Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients

    Not yet reported The First Affiliated Hospital of Xiamen University 156 participants Est. completion 2015-02 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01781234

    Efficacy Study of Intranasal Insulin to Treat Tobacco Abstinence Syndrome

    Not yet reported Ajna Hamidovic 51 participants Est. completion 2016-05 1 site Stand-alone
    Other conditions: Tobacco Abstinence Syndrome
    View official trial listing →
  • Completed NCT NCT01792284

    A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 212 participants Est. completion 2014-04 18 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01792323

    Absorption of Insulin Following Subcutaneous Bolus Administration With Different Bolus Durations

    Not yet reported Medical University of Graz 20 participants Est. completion 2014-01 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01797601

    Insulin Sensitivity of the Human CNS System: fMRI Study With Intranasal Insulin Application

    Not yet reported University Hospital Tuebingen 48 participants Est. completion 2014-04 1 site
    Other conditions: Obesity, Diabetes
    View official trial listing →
  • Status unknown NCT NCT01802944

    Intranasal Insulin: A Novel Treatment for Gulf War Multisymptom Illness

    Not yet reported Bronx Veterans Medical Research Foundation, Inc 114 participants Est. completion 2017-12 2 sites Stand-alone
    Other conditions: Chronic Multisymptom Illness in Gulf War Veterans
    View official trial listing →
  • Completed NCT NCT01810952

    The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients

    Not yet reported Baylor College of Medicine 37 participants Est. completion 2013-09 1 site
    Other conditions: Hyperglycemia, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01811849

    Pharmacokinetic and Injection Site Toleration of BIOD-238 and BIOD-250 Compared to Humalog® in Subjects With Type 1 Diabetes

    Not yet reported Biodel 12 participants Est. completion 2012-12
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01845831

    Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes

    Not yet reported Emory University 292 participants Est. completion 2016-04 5 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01848990

    CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)

    Not yet reported Halozyme Therapeutics 456 participants Est. completion 2014-09 39 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01871493

    A Study of LY2605541 and Insulin Lispro Mixture in Healthy Participants

    Not yet reported Eli Lilly and Company 40 participants Est. completion 2013-09 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01908894

    Pharmacokinetic and Pharmacodynamic Properties of BIOD-123 and BIOD-125 Compared to Humalog® in Subjects With Type 1 Diabetes Including Assessments of Injection Site Toleration

    Not yet reported Biodel 12 participants Est. completion 2012-03
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01945099

    Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy

    Not yet reported Yale University 13 participants Est. completion 2016-07 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01969149

    Exenatide for Stress Hyperglycemia

    Not yet reported, Not yet reported Centre Hospitalier Universitaire de Besancon 110 participants Est. completion 2016-12 1 site
    Other conditions: Stress Hyperglycemia
    View official trial listing →
  • Withdrawn NCT NCT01971047

    Safety and Efficacy Study of Correcting Hyperglycemia in Patients With Diabetes Having Out-patient Surgery

    Not yet reported Emory University Est. completion 2018-09 1 site
    Type 2 diabetes Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT01974544

    Prevention and Treatment Of Diabetes Complications With Gastric Surgery or Intensive Medicines

    Not yet reported Pontificia Universidad Catolica de Chile 150 participants Est. completion 2016-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01981031

    A Trial to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes

    Not yet reported Adocia 21 participants Est. completion 2014-08 1 site
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02004366

    Linagliptin Inpatient Trial

    Not yet reported Emory University 295 participants Est. completion 2017-03 5 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02012465

    Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients

    Not yet reported Washington University School of Medicine 15 participants Est. completion 2015-05 1 site
    Type 2 diabetes Other conditions: Lymphoma, Hyperglycemia
    View official trial listing →
  • Completed NCT NCT02028871

    Intranasal Insulin for Weight Management During Smoking Cessation

    Not yet reported Ajna Hamidovic 26 participants Est. completion 2016-05 2 sites
    Other conditions: Tobacco Abstinence Syndrome
    View official trial listing →
  • Completed NCT NCT02029924

    A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes

    Not yet reported Adocia 37 participants Est. completion 2014-08 1 site
    Other conditions: Diabetes Mellitus Type 1
    View official trial listing →
  • Completed NCT NCT02064166

    Treatment of Parkinson Disease and Multiple System Atrophy Using Intranasal Insulin.

    Not yet reported Peter Novak 15 participants Est. completion 2015-09 1 site Stand-alone
    Other conditions: Parkinson Disease, Multiple System Atrophy
    View official trial listing →
  • Completed NCT NCT02111083

    A Study of 2 Different Formulations of Insulin Lispro in Healthy Participants

    Not yet reported Eli Lilly and Company 38 participants Est. completion 2014-08 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02131948

    Regulation of Endogenous Glucose Production by Brain Insulin Action

    Not yet reported University Health Network, Toronto 8 participants Est. completion 2014-07 1 site Stand-alone
    Other conditions: Insulin Resistance, Diabetes
    View official trial listing →
  • Completed NCT NCT02146651

    A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes

    Not yet reported Adocia 38 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Diabetes Mellitus Type 1
    View official trial listing →
  • Completed NCT NCT02152384

    A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin Requirements

    Not yet reported Eli Lilly and Company 28 participants Est. completion 2014-12 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02154477

    Effect of Intranasal Insulin on LH Concentrations in Man

    Not yet reported, Not yet reported Texas Tech University Health Sciences Center 14 participants Est. completion 2017-12 1 site
    Other conditions: Hypogonadotropic Hypogonadism
    View official trial listing →
  • Completed NCT NCT02155023

    Feasibility Study to Determine the Optimal Calibration Method for Glucose Sensors

    Not yet reported Medical University of Graz 8 participants Est. completion 2015-01 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT02164032

    The Role of IntraNasal Insulin in Regulating HepaTic Lipid COntent in HUMANS

    Not yet reported Medical University of Vienna 20 participants Est. completion 2016-12 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT02165566

    Humalog or Humulin for Intensive Insulin Therapy in Intensive Care Unit

    Not yet reported University of Roma La Sapienza 28 participants Est. completion 2014-05 1 site
    Other conditions: Hyperglycemia
    View official trial listing →
  • Terminated NCT NCT02189395

    Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting

    Not yet reported Riverside University Health System Medical Center 52 participants Est. completion 2017-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02192424

    Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial)

    Not yet reported Mount Sinai Hospital, Canada 109 participants Est. completion 2020-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02194595

    Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)

    Not yet reported Mount Sinai Hospital, Canada 105 participants Est. completion 2022-02 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02197520

    A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 Diabetics

    Not yet reported Eli Lilly and Company 24 participants Est. completion 2015-06 1 site
    Type 2 diabetes
    View official trial listing →
  • Withdrawn NCT NCT02206568

    Pharmacokinetics of Ultra-Rapid-Acting Insulin Lispro (URAL) in Type 1 Diabetes Mellitus

    Not yet reported Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. Est. completion 2014-09 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02212951

    Comparison of Postprandial Glucose Control Associated With BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500

    Not yet reported, Not yet reported Biodel 12 participants 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02213146

    A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes

    Not yet reported, Not yet reported Adocia 38 participants Est. completion 2015-06 1 site Stand-alone
    Other conditions: Diabetes Mellitus Type 1
    View official trial listing →
  • Completed NCT NCT02221323

    A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1

    Not yet reported Profil Institut für Stoffwechselforschung GmbH 18 participants Est. completion 2014-11 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02227862

    Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)

    Not yet reported Mylan Inc. 558 participants Est. completion 2016-07 162 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02229227

    Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus

    Not yet reported GlaxoSmithKline 814 participants Est. completion 2017-07-24 157 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02248454

    Insulin Bolus Required for High Fat Foods in Type 1 Diabetes

    Not yet reported Joslin Diabetes Center 10 participants Est. completion 2015-04
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Withdrawn NCT NCT02250794

    Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit

    Not yet reported Rush University Medical Center Est. completion 2015-05
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02273180

    Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine

    Not yet reported Sanofi 507 participants Est. completion 2016-07 89 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02273258

    A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 Diabetes

    Not yet reported Sanofi 30 participants Est. completion 2013-07 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02276859

    Normal Versus Dual Wave Insulin Bolus for High-protein Food

    Not yet reported Medical University of Warsaw 70 participants Est. completion 2015-09 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02293551

    A Study of Lispro Formulations in Healthy Participants

    Not yet reported Eli Lilly and Company 54 participants Est. completion 2015-09 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02294474

    Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine

    Not yet reported Sanofi 505 participants Est. completion 2016-02 103 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02317575

    A Study of LY900014 Formulations in Healthy Participants

    Not yet reported Eli Lilly and Company 29 participants Est. completion 2015-09 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02324309

    BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control in Patients With Severe Insulin Resistance

    Not yet reported, Not yet reported Biodel 12 participants 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02344992

    Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal

    Not yet reported Adocia 38 participants Est. completion 2015-06 1 site
    Other conditions: Diabetes Mellitus Type 1
    View official trial listing →
  • Completed NCT NCT02415556

    Memory Aid by Intranasal Insulin in Diabetes (MemAID)

    Not yet reported Beth Israel Deaconess Medical Center 289 participants Est. completion 2020-05-31 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02416765

    Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes

    Not yet reported Institut de Recherches Cliniques de Montreal 15 participants Est. completion 2015-10 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02417090

    Late Metabolic Effects of Metformin Therapy in Gestational Diabetes

    Turku University Hospital 173 participants Est. completion 2019-12-01
    Other conditions: Gestational Diabetes
    View official trial listing →
  • Completed NCT NCT02432976

    Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients

    Not yet reported, Not yet reported Centre Hospitalier Universitaire de Besancon 64 participants Est. completion 2017-01 1 site
    Other conditions: Quality of Life
    View official trial listing →
  • Completed NCT NCT02443402

    Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery

    Not yet reported Emory University 68 participants Est. completion 2016-12 4 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02443714

    Pharmacokinetic and Pharmacodynamic Profile of Insulin Lispro Using Needle-Free Jet Injection Technology

    Not yet reported Chongqing Medical University 18 participants Est. completion 2015-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Suspended NCT NCT02446028

    A Study Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog® Mix 75/25 in Subjects With Type 2 Diabetes

    Not yet reported Biodel 13 participants Est. completion 2016-05 7 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02451917

    Glargine Versus NPH in Patients With Chronic Kidney Disease

    Not yet reported University of Sao Paulo General Hospital 34 participants Est. completion 2016-08 1 site Stand-alone
    Type 2 diabetesChronic kidney disease
    View official trial listing →
  • Completed NCT NCT02468999

    Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight Humans

    Not yet reported University Hospital Tuebingen 21 participants Est. completion 2015-12 1 site
    Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT02470637

    Single Dose Clamp Study to Evaluate Concentration-time Profile and Metabolic Activity of 3 Dose Levels of Afrezza and 3 Dose Levels of Insulin Lispro in Patients With Type 1 Diabetes Mellitus

    Not yet reported Mannkind Corporation 30 participants Est. completion 2015-09 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Withdrawn NCT NCT02488616

    Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes

    Not yet reported Institut de Recherches Cliniques de Montreal Est. completion 2018-11 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Withdrawn NCT NCT02490098

    Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes

    Not yet reported Institut de Recherches Cliniques de Montreal Est. completion 2018-07 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02500979

    Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus

    Not yet reported AstraZeneca 34 participants Est. completion 2016-08-05 3 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT02503501

    Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease

    Not yet reported HealthPartners Institute 49 participants Est. completion 2019-02-15 2 sites
    Other conditions: Mild Cognitive Impairment, Alzheimer's Disease (AD)
    View official trial listing →
  • Completed NCT NCT02509429

    Comparison of an Artificial Pancreas Versus Threshold Low Glucose Suspend in Type 1 Diabetic Children

    Not yet reported University Hospital, Montpellier 24 participants Est. completion 2016-12 4 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02514850

    A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes

    Not yet reported Adocia 24 participants Est. completion 2015-11 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02514954

    Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus

    Not yet reported Adocia 28 participants Est. completion 2015-11 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Withdrawn NCT NCT02518022

    How to be Safe With Alcoholic Drinks in Diabetes

    Not yet reported Kinderkrankenhaus auf der Bult Est. completion 2016-06 1 site
    Other conditions: Type 1 Diabetes Mellitus, Hypoglycemia
    View official trial listing →
  • Completed NCT NCT02518945

    Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes

    Not yet reported University at Buffalo 26 participants Est. completion 2016-04 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02525744

    A Study of a New LY900014 Formulation in Healthy Participants

    Not yet reported Eli Lilly and Company 24 participants Est. completion 2015-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02526810

    Comparison of Glycaemic Fluctuation and Oxidative Stress Between Two Short-term Therapies for Type 2 Diabetes

    Not yet reported Third Affiliated Hospital, Sun Yat-Sen University 70 participants Est. completion 2016-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02528396

    To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus

    Not yet reported Adocia 36 participants Est. completion 2015-12 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02529293

    A Clinical Trial Investigating the Intra-subject Variability of Pharmacokinetics and Glucodynamics of BioChaperone Insulin Lispro U-100 Product and U-200 Product in Healthy Volunteers

    Not yet reported Adocia 26 participants Est. completion 2015-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02556840

    Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes

    Not yet reported Assistance Publique - Hôpitaux de Paris 46 participants Est. completion 2020-12-09 1 site Stand-alone
    Other conditions: Maturity-Onset Diabetes of the Young
    View official trial listing →
  • Completed NCT NCT02556918

    Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery

    Not yet reported Emory University 202 participants Est. completion 2018-11-06 3 sites
    Other conditions: Hyperglycemia
    View official trial listing →
  • Completed NCT NCT02562313

    A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog®

    Not yet reported Adocia 80 participants Est. completion 2016-11 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02562326

    A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus

    Not yet reported Adocia 51 participants Est. completion 2016-01 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02603510

    Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion

    Not yet reported Sanofi 27 participants Est. completion 2016-04 2 sites Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Withdrawn NCT NCT02623452

    A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection Therapy

    Not yet reported Eli Lilly and Company Est. completion 2018-04
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Withdrawn NCT NCT02623465

    A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection Therapy

    Not yet reported Eli Lilly and Company Est. completion 2018-04
    Type 2 diabetes
    View official trial listing →
  • Withdrawn NCT NCT02623478

    A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps

    Not yet reported Eli Lilly and Company Est. completion 2018-04
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02626936

    Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation

    Not yet reported Institut de Recherches Cliniques de Montreal 10 participants Est. completion 2016-06 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02636361

    A Study of Various Formulations of LY900014 in Healthy Participants

    Not yet reported Eli Lilly and Company 26 participants Est. completion 2016-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02660502

    An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects

    Not yet reported Adocia 15 participants Est. completion 2016-05 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02666430

    Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients

    Not yet reported Mylan Inc. 127 participants Est. completion 2017-07 81 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT02685449

    Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.

    Not yet reported Medical University of Warsaw 70 participants Est. completion 2018-08 1 site
    Other conditions: Diabetes type1
    View official trial listing →
  • Completed NCT NCT02688933

    A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus

    Not yet reported Sanofi 638 participants Est. completion 2017-06-19 100 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02690883

    Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy

    Not yet reported Nanfang Hospital, Southern Medical University 92 participants Est. completion 2019-12-30
    Other conditions: Diabetic Nephropathies
    View official trial listing →
  • Terminated NCT NCT02701257

    The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas

    Not yet reported Massachusetts General Hospital 20 participants Est. completion 2018-05 1 site
    Other conditions: Diabetes Mellitus Type 1
    View official trial listing →
  • Completed NCT NCT02703324

    A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps

    Not yet reported Eli Lilly and Company 30 participants Est. completion 2016-08 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02703337

    A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy

    Not yet reported Eli Lilly and Company 30 participants Est. completion 2016-08 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02703350

    A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy

    Not yet reported Eli Lilly and Company 30 participants Est. completion 2016-07 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02713841

    Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes

    Not yet reported, Not yet reported Dance Biopharm Inc. 12 participants Est. completion 2013-07
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02716610

    Dose-Response and Variability of Inhaled Insulin in Type 2 Diabetes

    Not yet reported, Not yet reported Dance Biopharm Inc. 24 participants Est. completion 2014-01
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02729064

    Intraoperative Nasal Insulin Effect on Plasma and CSF Insulin Concentration and Blood Glucose

    Not yet reported Hiroaki Sato, MD., PhD. 141 participants Est. completion 2021-09 1 site Stand-alone
    Other conditions: Ischemic Heart Disease, Aortic Aneurysm
    View official trial listing →
  • Completed NCT NCT02739906

    A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DM

    Not yet reported, Not yet reported Adocia 36 participants Est. completion 2016-08 2 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02741687

    Sitagliptin in Non-Diabetic Patients Undergoing General Surgery

    Not yet reported Emory University 80 participants Est. completion 2017-04 2 sites
    Other conditions: Hyperglycemia
    View official trial listing →
  • Completed NCT NCT02752087

    A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy Participants

    Not yet reported Eli Lilly and Company 24 participants Est. completion 2016-05 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02758691

    fMRI Study of Effects of Nasal Insulin on Memory

    Not yet reported Virginia Polytechnic Institute and State University 45 participants Est. completion 2017-05-10 Stand-alone
    Other conditions: Human Memory, Intranasal Insulin
    View official trial listing →
  • Completed NCT NCT02770521

    A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants

    Not yet reported Eli Lilly and Company 23 participants Est. completion 2016-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02794155

    Study of HDV Insulin Versus Insulin in Type 1 Diabetes Subjects (ISLE-1)

    Not yet reported Diasome Pharmaceuticals 157 participants Est. completion 2018-06-15 21 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02798250

    Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2

    Not yet reported Institut de Recherches Cliniques de Montreal 11 participants Est. completion 2017-03 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02810392

    Intranasal Insulin and Post-stroke Cognition: A Pilot Study

    Not yet reported Wake Forest University Health Sciences 20 participants Est. completion 2020-03-04 1 site
    Cardiovascular disease
    View official trial listing →
  • Withdrawn NCT NCT02811484

    Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes

    Not yet reported Weill Medical College of Cornell University Est. completion 2018-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02814123

    Effect of Basal-Bolus Closed-Loop Co-Administration of Insulin and Pramlintide on Improving the Glycemic Control in Type 1 Diabetes

    Not yet reported McGill University 28 participants Est. completion 2018-07-08 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02846831

    Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes

    Not yet reported Institut de Recherches Cliniques de Montreal 36 participants Est. completion 2020-01-27 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Withdrawn NCT NCT02846857

    Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes

    Not yet reported Institut de Recherches Cliniques de Montreal
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02855307

    Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes

    Not yet reported Institut de Recherches Cliniques de Montreal 37 participants Est. completion 2018-12 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02870361

    Influence of Central Nervous Insulin Sensitivity on Insulin Secretion

    Not yet reported University Hospital Tuebingen 15 participants Est. completion 2018-04 1 site
    Other conditions: Insulin Secretion
    View official trial listing →
  • Status unknown NCT NCT02871089

    Closed Loop From Onset in Type 1 Diabetes

    Not yet reported University of Cambridge 96 participants Est. completion 2024-07-31 7 sites
    Other conditions: Diabetes Mellitus, Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02915250

    A Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes

    Not yet reported Adocia 36 participants Est. completion 2017-06 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02933645

    Effects of Intranasal Insulin Administration on Tissue Specific Insulin Sensitivity

    Not yet reported Turku University Hospital 10 participants Est. completion 2016-12 1 site
    Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT02942654

    A Study of LY900014 Formulation in Healthy Participants

    Not yet reported Eli Lilly and Company 32 participants Est. completion 2016-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02962921

    Insulin Effects on Cardiac Function in Patients With Diabetes Mellitus

    Not yet reported Rambam Health Care Campus 6 participants Est. completion 2004-11 1 site
    Other conditions: Diabetes Mellitus, Ventricular Dysfunction
    View official trial listing →
  • Completed NCT NCT02971228

    Feasibility Trial Testing the Bionic Pancreas With ZP4207

    Not yet reported Zealand Pharma 13 participants Est. completion 2017-06-07 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02988401

    Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis

    Not yet reported, Not yet reported Johns Hopkins University 105 participants Est. completion 2021-12-17 1 site Stand-alone
    Other conditions: Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive
    View official trial listing →
  • Completed NCT NCT03056456

    A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump

    Not yet reported Eli Lilly and Company 24 participants Est. completion 2017-06-19 2 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT03081117

    Intranasal Insulin for the Treatment of HAND

    Not yet reported, Not yet reported Johns Hopkins University 21 participants Est. completion 2020-10-16 1 site Stand-alone
    Other conditions: HIV Dementia, HIV-Associated Cognitive Motor Complex
    View official trial listing →
  • Completed NCT NCT03096392

    Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro to Further Improve Glycemic Control

    Not yet reported Diasome Pharmaceuticals 46 participants Est. completion 2018-03-18 5 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03102476

    Environmental Effects Type 1 Diabetes Mellitus

    Not yet reported University of Hull 10 participants Est. completion 2018-02-02 1 site
    Other conditions: Type1diabetes
    View official trial listing →
  • Completed NCT NCT03141827

    The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein Production

    Not yet reported, Not yet reported University Health Network, Toronto 9 participants Est. completion 2017-04-26 1 site
    Other conditions: Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT03156361

    21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus

    Not yet reported Diasome Pharmaceuticals 24 participants Est. completion 2018-03-15 1 site
    Other conditions: Type1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03166124

    A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 80 participants Est. completion 2017-11-18 2 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03170544

    Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001)

    Not yet reported Merck Sharp & Dohme LLC 69 participants Est. completion 2018-11-08 1 site Stand-alone
    Type 2 diabetes Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03179332

    A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump

    Not yet reported Adocia 43 participants Est. completion 2017-09-27 1 site
    Other conditions: Type1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03180710

    A Trial to Investigate the Dose-linearity of BioChaperone® Combo 75/25 and the Safety at Three Different Doses in Subjects With Type 2 Diabetes

    Not yet reported Adocia 32 participants Est. completion 2017-12-21 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03182322

    PINIT Study: Primary Intranasal Insulin Trial

    Not yet reported Technical University of Munich 38 participants Est. completion 2021-06-07 2 sites Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03214367

    A Study of LY900014 in Participants With Type 1 Diabetes

    Not yet reported Eli Lilly and Company 1392 participants Est. completion 2019-08-22 172 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03214380

    A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes

    Not yet reported Eli Lilly and Company 933 participants Est. completion 2019-03-13 141 sites
    Type 2 diabetes
    View official trial listing →
  • Withdrawn NCT NCT03229850

    Dynamics of Insulin Absorption in Subclinical Lipohypertrophy Using the Euglycemic Clamp Technique

    Not yet reported Graydon Meneilly Est. completion 2025-04-22 1 site
    Other conditions: Diabetes Mellitus, Lipohypertrophy
    View official trial listing →
  • Completed NCT NCT03232983

    A Study of LY900014 Formulation at Different Injection Sites in Healthy Participants

    Not yet reported Eli Lilly and Company 28 participants Est. completion 2017-11-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03234491

    Improving Post-Prandial Blood Glucose Control With Afrezza During Closed-Loop Therapy

    Not yet reported Yale University 15 participants Est. completion 2019-07-22 1 site
    Other conditions: Post-Prandial Hyperglycemia, Post-Prandial Hypoglycemia
    View official trial listing →
  • Withdrawn NCT NCT03248271

    Effects of Insulin on Hypotension and Sarcopenia

    Kenneth Madden Est. completion 2023-01-10 1 site
    Other conditions: Diabetes, Sarcopenia, Hypotension, Orthostatic
    View official trial listing →
  • Terminated NCT NCT03260868

    Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Diabetes Mellitus (eStudy)

    Not yet reported Sanofi 15 participants Est. completion 2018-11-22 6 sites Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT03262116

    Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas

    Not yet reported, Not yet reported Massachusetts General Hospital 20 participants Est. completion 2019-07-23 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT03277222

    Intranasal Treatment of HIV-associated Neurocognitive Disorders

    Not yet reported University of Calgary 4 participants Est. completion 2019-04-21 1 site
    Other conditions: HIV Associated Neurocognitive Disorder (HAND)
    View official trial listing →
  • Completed NCT NCT03286751

    A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants

    Not yet reported Eli Lilly and Company 42 participants Est. completion 2018-02-06 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03305822

    A Study of LY900014 in Participants With Type 2 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 38 participants Est. completion 2017-12-14 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT03307512

    PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD

    Not yet reported Dance Biopharm Inc. 40 participants Est. completion 2019-08-30 1 site
    Other conditions: Safety and Tolerability
    View official trial listing →
  • Status unknown NCT NCT03320031

    A Study of Adding Linagliptin to Control Glycemic Variability and HbA1c in Peritoneal Dialysis Patients With Type 2 Diabetes(PDPD) With Premixed Insulin Therapy

    Not yet reported Yanbing Li 232 participants Est. completion 2019-12 1 site Stand-alone
    Type 2 diabetes Other conditions: Peritoneal Dialysis
    View official trial listing →
  • Status unknown NCT NCT03324867

    The Effect of Intranasal Insulin Administration on Cognitive Function After Cardiac Surgery.

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 316 participants Est. completion 2023-04 Stand-alone
    Other conditions: Cognitive Decline, Heart Diseases, Delirium
    View official trial listing →
  • Completed NCT NCT03328845

    Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study)

    Not yet reported Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 300 participants Est. completion 2021-11-20 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03334448

    A Study to Compare 2 Formulations of LY900014 in Healthy Participants

    Not yet reported Eli Lilly and Company 49 participants Est. completion 2018-03-15 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03338023

    A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 272 participants Est. completion 2020-03-05 20 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT03341299

    A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 36 participants Est. completion 2018-04-03 2 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03341312

    A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM)

    Not yet reported Eli Lilly and Company 36 participants Est. completion 2018-03-31 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03350984

    Insulin Schemes for Type 2 Diabetes Control

    Not yet reported Universidad de Guanajuato 75 participants Est. completion 2018-07-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03367390

    A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)

    Not yet reported Eli Lilly and Company 30 participants Est. completion 2018-02-09 1 site
    Other conditions: Type1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03368807

    Assessment of Mealtime Bolus Insulin Behavior

    Eli Lilly and Company 79 participants Est. completion 2018-07-23 6 sites
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03383822

    Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance

    Not yet reported, Not yet reported University Health Network, Toronto 7 participants Est. completion 2017-12-01 1 site Stand-alone
    Other conditions: Insulin Resistance
    View official trial listing →
  • Completed NCT NCT03407118

    A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 31 participants Est. completion 2018-07-12 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT03415061

    Effect of Intranasal Insulin on POCD and POD

    Not yet reported Hiroaki Sato, MD., PhD. 494 participants Est. completion 2024-11-30 1 site Stand-alone
    Other conditions: Delirium, Heart Diseases
    View official trial listing →
  • Completed NCT NCT03433677

    A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes

    Not yet reported Eli Lilly and Company 49 participants Est. completion 2018-09-04 5 sites Stand-alone
    Other conditions: Diabetes Type 1
    View official trial listing →
  • Completed NCT NCT03449433

    A Meal Test Study of LY900014 in Participants With Type 1 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 80 participants Est. completion 2018-08-14 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03465878

    A Study of LY900014 in Participants With Type 1 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 56 participants Est. completion 2019-11-14 2 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03495908

    Regular Insulin vs Rapid Insulin Delivered by V-Go

    Not yet reported East Coast Institute for Research 136 participants Est. completion 2019-08-12 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03507829

    Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients

    Not yet reported Medical University of Vienna 263 participants Est. completion 2018-05-22
    Other conditions: Hyperglycemia
    View official trial listing →
  • Completed NCT NCT03509324

    Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 Diabetes

    Not yet reported Sun Yat-sen University 67 participants Est. completion 2015-06-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03512236

    A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus

    Not yet reported Adocia 24 participants Est. completion 2019-02-14 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT03547427

    Glucagon Counterregulation in Type 1 Diabetes

    Not yet reported University of Virginia 13 participants Est. completion 2019-03-11 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT03563794

    Efficacy and Safety of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion in Uncontrolled Type 2 Diabetes

    Not yet reported The First Affiliated Hospital of Xiamen University 400 participants Est. completion 2019-12-10 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03565666

    The Insulin-Only Bionic Pancreas Bridging Study

    Not yet reported, Not yet reported Massachusetts General Hospital 36 participants Est. completion 2018-11-19 3 sites Stand-alone
    Other conditions: Type1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03604575

    A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro to Humalog® in Healthy Subjects

    Not yet reported Geropharm 28 participants Est. completion 2016-12-26 1 site
    Other conditions: Clamp Study
    View official trial listing →
  • Completed NCT NCT03606018

    A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro Mix 25 to Humalog® Mix 25 in Healthy Subjects

    Not yet reported Geropharm 48 participants Est. completion 2017-07-13 2 sites
    Other conditions: Clamp Study
    View official trial listing →
  • Completed NCT NCT03616977

    Study to Compare 2 Formulations of LY900014 in Healthy Participants

    Not yet reported Eli Lilly and Company 69 participants Est. completion 2018-10-19 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03632681

    Effect of Intranasal Insulin on Cognitive Processes and Appetite

    Not yet reported University of Birmingham 64 participants Est. completion 2019-04-01 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03637075

    Raclopride-PET/MRT

    Not yet reported University Hospital Tuebingen 24 participants Est. completion 2023-12-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT03660553

    Simplified Insulin Regimen for the Elderly

    Not yet reported University of Miami 7 participants Est. completion 2022-06-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03662334

    A Study of Continuous Subcutaneous Insulin Infusion (CSII) Pump Function in Subjects With Type 1 Diabetes With Recombinant Human Hyaluronidase (rHuPH20)

    Not yet reported Halozyme Therapeutics 14 participants Est. completion 2014-02-27 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03670641

    Remission Through Early Monitored Insulin Therapy - Duration Month

    Not yet reported Sandra Sobel 10 participants Est. completion 2020-07-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03682640

    Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes

    Not yet reported Uppsala University 60 participants Est. completion 2021-12-31 1 site
    Other conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Metabolic Disease, Glucose Metabolism Disorders, Endocrine System Diseases, Juvenile Diabetes, Insulin Dependent Diabetes, Type 1 Diabetes Mellitus, Inflammation, Diet Modification
    View official trial listing →
  • Completed NCT NCT03740919

    A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes

    Not yet reported Eli Lilly and Company 751 participants Est. completion 2021-07-02 111 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Active, not recruiting NCT NCT03741478

    Intranasal Insulin and Olanzapine Study in Healthy Volunteers

    Not yet reported Centre for Addiction and Mental Health 64 participants Est. completion 2026-07-30 2 sites Stand-alone
    Other conditions: Healthy Controls
    View official trial listing →
  • Completed NCT NCT03743285

    A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D)

    Not yet reported Eli Lilly and Company 10 participants Est. completion 2019-01-28 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03760640

    A Study of LY900014 in a Medtronic Pump

    Not yet reported Eli Lilly and Company 42 participants Est. completion 2019-10-07 2 sites
    Other conditions: Type1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03830281

    A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy

    Not yet reported Eli Lilly and Company 471 participants Est. completion 2020-01-06 83 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03848767

    A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus During Meal Challenges

    Not yet reported Eli Lilly and Company 10 participants Est. completion 2019-04-01 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03849612

    A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 10 participants Est. completion 2019-03-27 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03890003

    A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes

    Not yet reported Eli Lilly and Company 10 participants Est. completion 2019-05-06 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03903016

    A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type 1 Diabetes

    Not yet reported Sanofi 90 participants Est. completion 2019-08-19 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT03915613

    Brain Insulin Resistance in Mood Disorders

    Not yet reported, Not yet reported University Health Network, Toronto 150 participants Est. completion 2024-10-05 1 site Stand-alone
    Other conditions: Major Depressive Disorder, Bipolar Disorder, Anhedonia, Intranasal Insulin
    View official trial listing →
  • Completed NCT NCT03916640

    A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus

    Not yet reported Adocia 24 participants Est. completion 2019-03-01 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03929419

    "Effect of Central Insulin Administration on Whole-body Insulin Sensitivity in Women"

    Not yet reported University Hospital Tuebingen 29 participants Est. completion 2021-04-30 1 site
    Other conditions: Insulin Sensitivity
    View official trial listing →
  • Completed NCT NCT03938740

    Comparison of Different Insulin Dosing Algorithms Using Hepatic Directed Vesicle-Insulin Lispro and Insulin Degludec

    Not yet reported Diasome Pharmaceuticals 61 participants Est. completion 2020-03-18 7 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03943537

    Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders

    Not yet reported Mclean Hospital 87 participants Est. completion 2024-02-23 1 site Stand-alone
    Other conditions: Psychosis, Schizophrenia, Schizo Affective Disorder, Bipolar I Disorder
    View official trial listing →
  • Completed NCT NCT03952130

    A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes

    Not yet reported Eli Lilly and Company 354 participants Est. completion 2022-01-10 30 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03952143

    A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes

    Not yet reported Eli Lilly and Company 628 participants Est. completion 2021-01-20 41 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04019821

    Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal

    Not yet reported Medical University of Warsaw 72 participants Est. completion 2023-04-01 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT04023344

    Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients

    Not yet reported Geropharm 210 participants Est. completion 2019-04-18 18 sites
    Type 2 diabetes Other conditions: Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT04028960

    IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase

    Not yet reported HealthPartners Institute 4 participants Est. completion 2020-04-08 1 site
    Other conditions: Type1diabetes
    View official trial listing →
  • Completed NCT NCT04031599

    Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels

    Not yet reported Institut de Recherches Cliniques de Montreal 30 participants Est. completion 2021-12-14 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT04044534

    Intranasal Insulin for Posttraumatic Stress Disorder

    Not yet reported VA Connecticut Healthcare System 10 participants Est. completion 2026-05-28 1 site Stand-alone
    Other conditions: PTSD
    View official trial listing →
  • Completed NCT NCT04049123

    A Study of LY900014 in Healthy Chinese Participants

    Not yet reported Eli Lilly and Company 15 participants Est. completion 2020-10-23 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT04079881

    Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes

    Not yet reported, Not yet reported Washington University School of Medicine 1 participants Est. completion 2020-07-01 1 site Stand-alone
    Other conditions: Type 1 Diabetes, Hyperglycemia, Postprandial
    View official trial listing →
  • Completed NCT NCT04100473

    Dose Response of Dance 501 in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Dance Biopharm Inc. 24 participants Est. completion 2019-08-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04112069

    The Insulin-Only Bionic Pancreas Bridging Study- Pediatric Transitional Study

    Not yet reported Massachusetts General Hospital 20 participants Est. completion 2018-11-19 3 sites Stand-alone
    Other conditions: Type1 Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT04115384

    Intranasal Insulin in Frontotemporal Dementia (FTD)

    Not yet reported HealthPartners Institute 3 participants Est. completion 2023-05-15 1 site
    Other conditions: Frontotemporal Dementia, Behavioral Variant
    View official trial listing →
  • Completed NCT NCT04124302

    The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.

    Not yet reported Medical University of Warsaw 76 participants Est. completion 2024-12-31 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT04149262

    Fiasp® Versus NovoRapid® in Children With Type 1 Diabetes on MiniMed 640G Pump With Sensor

    Aristotle University Of Thessaloniki 44 participants Est. completion 2023-02-15 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT04154449

    Effect of Intranasal Insulin on Postoperative Cognitive Dysfunction

    Minia University 57 participants Est. completion 2019-12-25 2 sites
    Other conditions: Middle Aged Patients
    View official trial listing →
  • Completed NCT NCT04157738

    A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus

    Not yet reported Emory University 24 participants Est. completion 2020-12-17 1 site
    Other conditions: Diabetes Mellitus, Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT04161976

    A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 20 participants Est. completion 2020-07-14 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT04196231

    Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)

    Not yet reported University of Campania Luigi Vanvitelli 258 participants Est. completion 2020-10-20 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04200313

    The Insulin-Only Bionic Pancreas Pivotal Trial

    Not yet reported Jaeb Center for Health Research 440 participants Est. completion 2022-01-14 16 sites
    Other conditions: Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT04235439

    PK/PD Biosimilarity Study of Gan & Lee Insulin Lispro Injection vs. EU and US Humalog® in Healthy Males

    Not yet reported Gan and Lee Pharmaceuticals, USA 36 participants Est. completion 2019-07-03 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT04243629

    Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes

    Not yet reported McGill University 26 participants Est. completion 2024-04 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1, Type 1 Diabetes, Postprandial Hyperglycemia
    View official trial listing →
  • Completed NCT NCT04251585

    Intranasal Insulin in Parkinson's Disease

    Not yet reported HealthPartners Institute 31 participants Est. completion 2024-08-27 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Withdrawn NCT NCT04254380

    Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro

    Not yet reported Gan and Lee Pharmaceuticals, USA Est. completion 2020-01-27 107 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT04276207

    A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps

    Not yet reported Eli Lilly and Company 32 participants Est. completion 2020-08-10 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT04292535

    Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise

    Not yet reported Michigan State University 116 participants Est. completion 2020-02-20 1 site
    Other conditions: Insulin, Exercise
    View official trial listing →
  • Terminated NCT NCT04416269

    Oral Anti Diabetic Agents in the Hospital

    Not yet reported Emory University 85 participants Est. completion 2025-04-11 3 sites Added to GLP-1
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT04484779

    A Study of an Insulin Management System in Participants With Type 1 or Type 2 Diabetes

    Not yet reported Eli Lilly and Company 67 participants Est. completion 2020-12-22 5 sites
    Type 2 diabetes Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT04501107

    A Trial to Compare BioChaperone Insulin Lispro Formulations With US Approved Humalog® and With EU Approved Humalog® in Patients With Type 1 Diabetes Mellitus

    Not yet reported Adocia 32 participants Est. completion 2020-11-03 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT04537923

    A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin

    Not yet reported Eli Lilly and Company 1428 participants Est. completion 2022-11-01 135 sites
    Type 2 diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT04542148

    Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes

    Not yet reported University of Alabama at Birmingham 120 participants Est. completion 2026-12-31 4 sites
    Type 2 diabetes Other conditions: Preterm Birth, Pregnancy, High Risk, Diabetes, Gestational
    View official trial listing →
  • Withdrawn NCT NCT04635774

    Post Operative Delirium Study

    Not yet reported, Not yet reported University of Kansas Medical Center Est. completion 2023-11-14 1 site
    Other conditions: Delirium
    View official trial listing →
  • Completed NCT NCT04687878

    The Effect of Intranasal Insulin on Motor and Non-motor Symptoms in Parkinson's Disease Patients

    Not yet reported dr.dargahi 28 participants Est. completion 2023-09-20 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Status unknown NCT NCT04690309

    Human Versus Analogue Insulin in Patients After Pancreatectomy.

    Not yet reported Polish Society of Diabetology 100 participants Est. completion 2021-12-31 1 site
    Other conditions: Pancreatogenous Diabetes
    View official trial listing →
  • Completed NCT NCT04739241

    Premixed vs Basal Bolus Insulin Therapy in Older Patients With Type 2 Diabetes

    Not yet reported Consorci Sanitari Integral 60 participants Est. completion 2018-06-19
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04739371

    Food Intake and Intra-Nasal Insulin for African American Adults (FIINAAL)

    Not yet reported Pennington Biomedical Research Center 40 participants Est. completion 2022-06-07 1 site Stand-alone
    Other conditions: Insulin
    View official trial listing →
  • Completed NCT NCT04783376

    Effect of Splitting Mealtime Insulin Doses After Mixed Meals High in Fat and Protein

    Not yet reported Sohag University 43 participants Est. completion 2022-03-03 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT04816890

    A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM)

    Not yet reported Adocia 80 participants Est. completion 2022-02-24 2 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT04965051

    Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 40 participants Est. completion 2023-12 1 site
    Other conditions: Type 1 Diabetes Mellitus With Diabetic Gastroparesis, HbA1c, Time in Range
    View official trial listing →
  • Status unknown NCT NCT04972175

    Safety and Efficacy of BC LisPram

    Not yet reported Michael Tsoukas 16 participants Est. completion 2022-06 1 site
    Other conditions: Type1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT04974528

    Afrezza® INHALE-1 Study in Pediatrics

    Not yet reported Mannkind Corporation 319 participants Est. completion 2025-04-29 39 sites
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT04977908

    Closing the Loop in Adults With Type 1 Diabetes (CLEAR)

    Not yet reported University of Cambridge 26 participants Est. completion 2023-05-31 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT05062785

    Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants

    Not yet reported Robert Silbergleit 24 participants Est. completion 2022-04-25 1 site Stand-alone
    Other conditions: Out-Of-Hospital Cardiac Arrest, Healthy
    View official trial listing →
  • Completed NCT NCT05067270

    A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 40 participants Est. completion 2021-12-06 2 sites Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT05081219

    SNIFF - Combo INI+EMPA Trial

    Not yet reported Wake Forest University Health Sciences 47 participants Est. completion 2024-09-17 1 site Stand-alone
    Other conditions: Mild Cognitive Impairment, Cognitive Impairment, Alzheimer Disease
    View official trial listing →
  • Status unknown NCT NCT05104424

    The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post COVID-19 Smell and Taste Dysfunctions

    Not yet reported Ministry of Health, Saudi Arabia 22 participants Est. completion 2022-10-01
    Other conditions: Smell Dysfunction, Taste Disorders, Taste Disorder, Secondary, Sweet, Taste Disorder, Secondary, Bitter, Smell Disorder
    View official trial listing →
  • Suspended NCT NCT05153395

    Impact of Intranasal Insulin on Sympathetic Activity and Cerebral Vasodilation

    Not yet reported University of Missouri-Columbia 65 participants Est. completion 2027-06 1 site
    Other conditions: Healthy, Vasodilation, Insulin Resistance, Autonomic Dysfunction, Obesity
    View official trial listing →
  • Completed NCT NCT05218915

    Basal Plus GLP1-ra on Glycemic Variability in CKD

    Not yet reported Elaine Chow 95 participants Est. completion 2024-10-30 1 site
    Chronic kidney disease Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT05257460

    Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions (AP@Home04_Phase 4)

    Not yet reported University of Cambridge 28 participants Est. completion 2023-03-25 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT05262387

    A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes

    Not yet reported Eli Lilly and Company 25 participants Est. completion 2023-03-07 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT05325294

    Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®

    Not yet reported Medtronic MiniMed, Inc. 244 participants Est. completion 2024-01-03 19 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT05373186

    A Trial Investigating the Pharmacodynamics of BC Combo THDB0207 Compared With Humalog® Mix25 and Simultaneous Injections of Humalog® and Lantus® in Healthy Chinese Volunteers

    Not yet reported Adocia 27 participants Est. completion 2022-12-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05373199

    A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus® and Humalog® in Subjects With Type 1 Diabetes

    Not yet reported Adocia 30 participants Est. completion 2022-10-28 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT05373212

    A Trial Investigating the Dose Linearity and Safety of BC Combo THDB0207 in Subjects With Type 2 Diabetes

    Not yet reported Adocia 40 participants Est. completion 2023-01-02 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05457933

    Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes

    Not yet reported Medanta, The Medicity, India 250 participants Est. completion 2023-01-14 1 site
    Cardiovascular disease Other conditions: Type2diabetes
    View official trial listing →
  • Completed NCT NCT05461365

    Intranasal Insulin for COVID-19-related Smell Loss

    Not yet reported Universidad Panamericana 27 participants Est. completion 2021-12-20 1 site Stand-alone
    Other conditions: Anosmia, Smell Loss, Paraosmia, Hyposmia, COVID-19
    View official trial listing →
  • Completed NCT NCT05462756

    A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections

    Not yet reported Eli Lilly and Company 730 participants Est. completion 2024-02-27 81 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05463744

    A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

    Not yet reported Eli Lilly and Company 692 participants Est. completion 2024-05-07 83 sites
    Other conditions: Type 1 Diabetes, Diabetes
    View official trial listing →
  • Completed NCT NCT05508061

    Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes

    Not yet reported Inreda Diabetic B.V. 12 participants Est. completion 2023-03-16 3 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT05543850

    Portable Artificial Pancreas Applied for Youth and Adolescents

    Not yet reported Inreda Diabetic B.V. 20 participants Est. completion 2023-05-19 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT05565976

    Dapagliflozin Effect in Cognitive Impairment in Stroke Trial

    Not yet reported, Not yet reported Jaime Daniel Mondragon 270 participants Est. completion 2025-07-01 1 site
    Cardiovascular diseaseMetabolic syndrome Other conditions: Mild Cognitive Impairment, Dementia, Vascular
    View official trial listing →
  • Completed NCT NCT05571878

    Is Brain Insulin Resistance a Feature of the Biology of Depression in Adolescents

    Not yet reported Centre for Addiction and Mental Health 24 participants Est. completion 2025-05-13 1 site Stand-alone
    Other conditions: Major Depressive Disorder, Depression
    View official trial listing →
  • Completed NCT NCT05579119

    SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)

    Not yet reported Hospital de Especialidades, Centro Medico Nacional "La Raza", Instituto Mexicano del Seguro Social 76 participants Est. completion 2023-08-24 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT05613491

    Intranasal Insulin Improves Postoperative Neurocognitive Disorders in Elderly Patients

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 438 participants Est. completion 2023-08-31 1 site Stand-alone
    Other conditions: Postoperative Neurocognitive Disorders
    View official trial listing →
  • Status unknown NCT NCT05660941

    Automated Fully Closed-Loop Insulin Delivery in Type 1 Diabetes With Ultra-Rapid Lispro (ACOLYTE Study)

    Not yet reported Manchester University NHS Foundation Trust 26 participants Est. completion 2024-05-01 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Not yet recruiting NCT NCT05689424

    Suppression of Endogenous Glucose Production by Injectable HDV-Insulin Lispro: A Dose Response Study in Human Subjects With Type 1 Diabetes

    Not yet reported University of California, San Diego 18 participants Est. completion 2026-06-30
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT05726461

    Efficacy and Safety of Android Artificial Pancreas System in Adult Patients With Type 1 Diabetes Mellitus in China

    Not yet reported Third Affiliated Hospital, Sun Yat-Sen University 25 participants Est. completion 2024-09-30 1 site
    Other conditions: Diabetes Mellitus, Diabetes Mellitus, Type 1, Glucose Metabolism Disorders, Metabolic Disease, Endocrine System Diseases, Autoimmune Diseases, Immune System Diseases
    View official trial listing →
  • Active, not recruiting NCT NCT05748990

    Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia

    Not yet reported Centre for Addiction and Mental Health 20 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Schizophrenia, Healthy
    View official trial listing →
  • Completed NCT NCT05834868

    Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes

    Not yet reported Tonghua Dongbao Pharmaceutical Co.,Ltd 1040 participants Est. completion 2024-12-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT05866367

    Measurement of Insulin Levels in Cerebral Spinal Fluid (CSF) of Healthy Adults After a Single Intranasal Dose

    Not yet reported HealthPartners Institute 2 participants Est. completion 2024-06-28 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05893797

    A Study of LY8888AX in Participants Using a Connected Insulin Management Platform

    Not yet reported Eli Lilly and Company 36 participants Est. completion 2024-09-16 9 sites Stand-alone
    Type 2 diabetes Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT06144255

    Dose-Dependent Effect of Intranasal Insulin in Humans Using Functional Magnetic Resonance Imaging (fMRI)

    Not yet reported Florian Schmitzberger 6 participants Est. completion 2024-02-22 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06153329

    A Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of THDB0206 Injection in Healthy Chinese Subjects

    Not yet reported Tonghua Dongbao Pharmaceutical Co.,Ltd 39 participants Est. completion 2022-06-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06238778

    Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec

    Not yet reported Diasome Pharmaceuticals 227 participants Est. completion 2025-12-16 27 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Active, not recruiting NCT NCT06295640

    Relative Contribution of Brain Insulin Action for Postprandial Metabolism

    Not yet reported University of Ulm 31 participants Est. completion 2026-06 1 site Stand-alone
    Other conditions: Glucose Metabolism Disorders
    View official trial listing →
  • Status unknown NCT NCT06346366

    Glucose Control Through a Bihormonal Artificial Pancreas in Patients After Total Pancreatectomy

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 40 participants Est. completion 2024-04-01 1 site Stand-alone
    Other conditions: Pancreatic Neoplasms, Type 3c Diabetes, Total Pancreatectomy
    View official trial listing →
  • Completed NCT NCT06370715

    A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India

    Not yet reported Eli Lilly and Company 150 participants Est. completion 2025-09-02 12 sites
    Type 2 diabetes
    View official trial listing →
  • Withdrawn NCT NCT06391853

    Investigating Brain Insulin Resistance in Alzheimer Disease with IntraNasal Insulin : a Multimodal Neuroimaging Study

    Not yet reported Erasme University Hospital Est. completion 2026-10-01 Stand-alone
    Other conditions: Alzheimer Disease, Mild Cognitive Impairment
    View official trial listing →
  • Withdrawn NCT NCT06434038

    Measurement of Insulin Levels in the Cerebrospinal Fluid of Healthy Adults After a Single Intranasal Dose - Middle Age

    Not yet reported HealthPartners Institute Est. completion 2026-02-28 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06443957

    The Preventive Effect of Different Doses of Intranasal Insulin on Postoperative Delirium

    Not yet reported The First Hospital of Jilin University 129 participants Est. completion 2024-04-13 1 site Stand-alone
    Other conditions: Postoperative Delirium
    View official trial listing →
  • Active, not recruiting NCT NCT06552130

    The Importance of Insulin Action in the Brain for the Immune System During Physical Activity

    Not yet reported University of Ulm 20 participants Est. completion 2026-09 1 site Stand-alone
    Other conditions: Insulin Sensitivity
    View official trial listing →
  • Not yet recruiting NCT NCT06600776

    Mealtime or Post-meal Dosing of URLi in Medtronic 780G Hybrid Closed Loop System

    Not yet reported Tel-Aviv Sourasky Medical Center 50 participants Est. completion 2025-10-21 1 site
    Other conditions: Type 1 Diabetes (T1D)
    View official trial listing →
  • Completed NCT NCT06741566

    Pre-operative Intra-nasal Dexmedetomidine or Insulin for Prevention of Early Post-operative Cognitive Dysfunction in Patients Undergoing Elective Coronary Artery Bypass Graft.

    Not yet reported Minia University 150 participants Est. completion 2026-05-15 1 site
    Other conditions: Post Operative Cognitive Dysfunction
    View official trial listing →
  • Enrolling by invitation NCT NCT06765655

    Perioperative Glucose Monitoring and Treatment to Reduce Risk of Surgical Site Infections and Complications

    Not yet reported St. Peter's Hospital, Albany, NY 266 participants Est. completion 2025-01-31 1 site
    Other conditions: Surgical Site Infections, Stress Hyperglycemia
    View official trial listing →
  • Completed NCT NCT06948760

    Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D

    Not yet reported Mark D. DeBoer, MD, MSc., MCR 11 participants Est. completion 2026-03-10 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT07090824

    Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes

    Not yet reported Stanford University 10 participants Est. completion 2026-05-29 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1, Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT07165652

    Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(L), US-Humalog®, and EU-Humalog®

    Not yet reported Xentria, Inc. 54 participants Est. completion 2026-03-02 1 site
    Other conditions: Healthy Male Adult Volunteers
    View official trial listing →
  • Not yet recruiting NCT NCT07252752

    Dopamine and Insulin in Psychosis

    Not yet reported Medical University of Vienna 46 participants Est. completion 2029-01-01 1 site Stand-alone
    Other conditions: First Episode Psychosis (FEP)
    View official trial listing →
  • Completed NCT NCT07282054

    Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes

    Not yet reported Tonghua Dongbao Pharmaceutical Co.,Ltd 550 participants Est. completion 2025-01-24 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Not yet recruiting NCT NCT07466173

    The Importance of Insulin Action in the Brain for the Immune System During Physical Activity-Overweight

    Not yet reported University of Ulm 8 participants Est. completion 2027-06 1 site Stand-alone
    Other conditions: Insulin Sensitivity
    View official trial listing →
  • Enrolling by invitation NCT NCT07521371

    Intranasal Insulin for Autism Spectrum Disorder in Children and Young Adults Aged 4 to 21 Years

    Healing Hope International 12 participants Est. completion 2030-01-30 1 site
    Other conditions: Autism Spectrum Disorder, Autism Spectrum Disorder (ASD), Autism Spectrum Disorder High-Functioning, Autism Spectrum Disorder With Absence of Functional Language, Autism Spectrum Disorder With Impaired Functional Language, Autistic Disorder of Childhood Onset With Full Syndrome, Autistic Disorders Spectrum, Autistic Disorder, Autistic Disorder in Children and Adolescents, Neurodevelopmental Disorders, Neurodevelopmental Disorders (NDD), Neurodevelopmental Disorders and Developmental Abnormalities
    View official trial listing →
  • Completed NCT NCT07532577

    Intranasal Insulin to Prevent Intensive Care Unit Delirium

    Not yet reported, Not yet reported Radboud University Medical Center 30 participants Est. completion 2026-07-30 1 site Stand-alone
    Other conditions: Delirium - Postoperative
    View official trial listing →
  • Not yet recruiting NCT NCT07720479

    Intranasal Insulin for Postoperative Delirium in Older Patients With T2DM

    Not yet reported Weidong Mi 210 participants Est. completion 2028-02-01 Stand-alone
    Other conditions: Postoperative Delirium (POD)
    View official trial listing →
  • Not yet recruiting NCT NCT07756294

    Restoring Vascular and Insulin Function To Augment Anti-Amyloid Therapy in Alzheimer's Disease

    Not yet reported Wake Forest University Health Sciences 30 participants Est. completion 2028-04 1 site Stand-alone
    Other conditions: Alzheimer Disease
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Intranasal insulin, Humalog

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.